Artificial Intelligence for Detection and Characterisation of Bone Metastases on MRI: A Scoping Review.
Authors
Affiliations (4)
Affiliations (4)
- Department of Diagnostic Imaging, National University Hospital, 5 Lower Kent Ridge Rd, Singapore 119074, Singapore.
- Department of Diagnostic and Interventional Imaging, KK Women's and Children's Hospital, 100 Bukit Timah Rd, Singapore 229899, Singapore.
- National University Spine Institute, Department of Orthopaedic Surgery, National University Health System, Singapore 119228, Singapore.
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, 10 Medical Drive, Singapore 117597, Singapore.
Abstract
<b>Background/Objectives</b>: Bone metastasis is one of the most common manifestations of advanced malignancy and a major cause of morbidity, particularly when involving the spine. Magnetic resonance imaging (MRI) plays a central role in its detection and characterisation due to its high sensitivity for bone marrow infiltration. However, bone metastases may be missed on MRI, whilst interpretation can be time-consuming and challenging. The purpose of this study is to review and summarise the present evidence for artificial intelligence (AI) applications in the detection and classification of bone metastasis on MRI. <b>Methods</b>: A systematic, detailed search of the main electronic medical databases (PubMed, MEDLINE, Web of Science, and clinicaltrials.gov, last accessed on 1 January 2026) was undertaken in concordance with the PRISMA guidelines. <b>Results</b>: A total of 34 studies were included. AI applications were identified across several domains, including lesion detection, segmentation, disease classification, and predictive modelling. Deep learning approaches demonstrated strong performance for automated detection and segmentation, while radiomics-based models were frequently used for lesion differentiation and prediction tasks. Reported performance metrics were generally high, with area under the curve values commonly ranging from approximately 0.72-0.94, with most studies reporting AUCs exceeding 0.80 in internal validation, although substantial heterogeneity in study design, datasets, and validation strategies was observed. External validation and prospective evaluation were limited across most studies. <b>Conclusions</b>: Within the domain of bone metastasis, AI-based approaches have demonstrated encouraging performance and hold substantial potential to support clinical decision-making, including prognostication and prediction of treatment response. Nevertheless, further research is required to validate their clinical utility and to facilitate successful integration into routine clinical practice.